Sign in
4

Changes in Ownership

Hepion Pharmaceuticals, Inc. Filed Acc 0001104659-20-044170

Options or other derivatives

  • CEO and CSO acquired 380,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Foster Robert T · CEO and CSO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-04-03 Grant or award : show line 1 in the form Stock Options +380,000 389,879 D
Loading xslF345X03/a4.xml…